Anebulo Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2025
Total Assets: $12.1M
Liabilities Breakdown FY2025
Total Liabilities: $487.7K
Asset Breakdown
Total Assets: $12.1M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $11.6M | 95.7% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $0 | 0.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $517.8K | 4.3% |
Liabilities Breakdown
Total Liabilities: $487.7K
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $224.2K | 46.0% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $263.5K | 54.0% |